The liver is involved in the turnover of fibronectin in two different ways: hepatic synthesis contributes substantially to the plasma fibronectin pool, while Kupffer-ce\\s, performing an important role of the reticuloendothelial System, remove fibronectin opsonized materi^l from the circulation.
In 45 patients with histologically confirmed liver cirrhosis and six patients with acute liver failure due to intoxication we determined fibronectin concentration in plasma by electroimmunoassay and additionally measured factor VHI-related antigen, which is a large glycoprotein not synthesized in the liver.
Fibronectin levels in plasma were decreased in liver cirrhosis. This decrease was correlated with the extent of porto-caval collateral circulation. Very low levels were found in patients with acute liver failure. Factor VIIIrelated antigen levels were greatly increased äs a function of the hepatic insufficiency. Between both parameters there was a significant inverse correlation. It is concluded that the simultaneous determination of both proteins provides reliable Information about the remaining liver function. fibrin, Collagen, heparin and bacteria etc., its funcIn its soluble form it is present in plasma and other tion has been compared to that of a molecular glue . body fluids, whereas in its insoluble form it is found (1).
Fibronectin und Faktor Vlll-assoziiertes Antigen bei Lebercirrhose und akutem Leberversagen
One of the important functions of fibronectin is that it acts äs a mediator of phagocytosis by macrophages and endothelial cells of the reticuloendothelial system (2) . Thus the term "az-surface binding opsonic glycoprotein" has also been used to characterize its function. A deficiency of plasma fibronectin following trauma, burn and sepsis has been correlated with systemic failure of reticuloendothelial System function (3, 4) . This, and the fact that fibronectin is synthesized in the liver (5), caused us to investigate plasma fibronectin levels in patients with liver failure. Simultaneously, the related large glycoprotein factor Vlll-related antigen was measured, which in contrast to fibronectin, is not synthesized in the liver (6), but is said to be a reliable marker for the clearance function of the reticuloendothelial System (7).
Materials and Methods

Patients
Forty-five patients with histologically confirmed liver cirrhosis were subdivided according to the severity of hepatic insufficiency using the extent of the porto-caval collateral circulation. This parameter was evaluated by laparoscopy and radiology.
Electroimmunoassay
Using the procedure of Laurell (8), electroimmunoassay was performed in a barbital buffer System (pH 8.6, ionic strength 0.02) on 5 cm square plates. An agarose gel 10 g/l was used, containing 6.6 ml/l anti-human fibronectin and anti-factor Vlll-related protein, respectively. Four of the plates were run on a thermostated dish. At l cm intervals, wells 3 mm in diameter were cut into the gel and filled with 7 of plasma dilutions to be assäyed. Electrophoresis was performed at 6 V/cm for 18 hours at 17 °C. The gels were then washed, dried and finally stained with Coomassie brilliant blue. A reference curve was set up using dilutions of the protein Standard plasma with the known fibronectin concentration. For factor Vlll-related antigen a pool of ten plasmas of healthy subjects served äs feference. Our experience with this method resulted in a Standard deviation of ±8% and ±10.6% for factor Vlll-related antigen and fibronectin, respectively, when the assays of the same sample were done on 8 different days.
Crossed-immunoelectrophoresis
Crossed-immunoelectrophoresis was performed on 10 cm square plates, according to Clarke & Freeman (9); the first dimension at 12 V/cm for 80 minutes and second dimension at 6 V/cm for 15 hours. In the second dimension, the antiserum concentration of anti-fibronectin and anti-factpr VHI-related protein was 6.6 ml/l agarose gel.
Statistical analysis
Means ± Standard deviation were computed from all data. Levels of significance were evaluated according to Studenfs t-test.
Group I, n = 10:
Patients without signs of porto-caval collateral circulation; Group II, n = 10:
Patients with porto-caval shunts: oesophageal varices, splenomegaly, reperfused umbilical veins and congested veins in ligamentum teres and ligamentum falciforme, äs well äs in the omentum maius;
Group III, n = 25:
Patients with signs of decompensated liver cirrhosis (e. g. ascites or liver coma).
A further group consisted of 6 patients with acute liver failure due to intoxication. Thirty-five healthy persons with no history of liver disease (23 male, 12 female) and with an age distribution between 18 and 82 served äs the control group.
Collection of samples
Venous blood was collected with sodium citrate äs the anticoagulant. After centrifugation at 5000 g for 20 minutes, plasma was stored at -34 °C until used.
Antisera
Anti-fibronectin serum from rabbits, anti-antihaemophilic globül-in (anti-factor VIII) related protein serum from rabbits, and protein Standard plasma with a fibronectin concentration of 250 mg/1 were obtained from Behringwerke AG, Marburg, West Germany.
Results
The concentration of fibronectin^ in plasma of patients with liver cirrhosis was significantly decreased äs soon äs there were any signs of a porto-caval collateral circulation (tab. 1). There were also significant differences between the cirrhosis subgroups. The lowest plasma fibronectin levels were found in patients with acute liver failure.
Factor Vlll-related antigen behaved quite differently. Its concentration was increased up to 20-fold in patients with cirrhosis, this increase being a function of the severity of the disease, namely from subgroups I to III (tab. 2). Very high levels were also found in patients with acute liver failure.
Between the fibronectin and the factor Vlll-related antigen plasma concentrations there was a significant negative correlation ( fig. 1) . We used crossed-immunoelectrophoresis with both antisera in the second dimension to demonstrate this relationship ( fig. 2) , thereby confirming that the high factor Vlll-related antigen concentrations found in the electroimmunoassay were not due to a modified-electrophoretic mobility of an altered protein. 
Discussion
Production sites of fibronectin in vivo are considered to be fibroblasts (10) , vascular endothelial cells (11), and hepatocytes (12) . A recent study pn fibronectin synthesis in the perf sed liver (5) indicates that hepatic synthesis contributes substantially to the plasma fibronectin pool. One property of the plasma fibronectin is that it can bind to a large number of particles and macromolecules and mediate their opsonization by cells of the reticuloendothelial System. A deficiency of plasma fibronectin, s well s a depression of the reticuloendothelial System may impair its clearance function (13) . This is observed in septicaemia, where the reticuloendothelial System is overloaded and the plasma fibronectin concentration is reduced (14) . In this case a Substitution of fibronectin was shown to improve the clinical state of the patients (15) . Similar conditions may occur in patients with liver cirrhosis because the liver synthesizes patt of the fibronectin, and Kupffer cells represent an important part of the reticuloendothelial system.
As presented in table l, there was a significant decline of plasma fibronectin s soon s signs of a porto-caval shunt were found. The most striking reduction occurred in patients with acute liver failure, due to intoxication. In these patients haemostatic abnormalities of disseininated intravascular coagulation were also registered, which may have contributed to the drastic fall of fibronectin concentration. Our results regarding the cirrhosis patients seem to be in contradiction to earlier publications where elevated fibronectin levels were described (16) , but the stages of liver cirrhosis we examined were different. We only found reduced levels of fibronectin in advanced disease, and all patients had an insufficiency of hepatic function. One explanation for the reduced fibronectin levels takes into consideration decreased In the second dimension anti-fibronectin and anti-factor VHI-related antigen serum was present. From left to right a plasma frorn the cirrhosis stage I, stage III-group and from a patient with severe acute liver failure are shown. In addition to the high fibronectin peak, the slower migrating factor VHI-related antigen precipitate is seen to increase äs the disease becomes mofe severe. The patient with acute liver failure showed the lowest fibronectin concentration of all examined patients, so that it was not even seen by this technique.
hepatic synthesis although there was a poor correlation to plasma albumin in our patients. Since it has been shown that fibronectin is susceptible to limited proteolysis by plasmin (17) , an increased catabolism of fibronectin due to an accelerated fibrinolysis may have contributed to the reduced plasma levels.
Plasma levels of factor VHI-related antigen increased äs a function of the severity of liver cirrhosis. Because this protein is not synthesized in the liver (6), we suppose that its increased plasma concentration reflects the depressed clearance function of the liver reticuloendothelial System (7). The possibility that this increase could be due to false results obtained by LaureWs technique caused by a modified mobility of an altered protein (18), was ruled out by using the two dimensional immunoelectrophoresis ( fig.2 ).
The simultaneous determination of the two related glycoproteins, fibronectin and factor Vltt-related antigen, in patients with liver disease inay supply Information about the synthesis and catabolism of fibronectin and the clearance function of the liver reticuloendothelial system. In cases with hepatic insufficiency and septic complications a Substitution of fibronectin should be taken into consideration.
